Why? As we’ve already discussed, we don’t know what proportion of people in that unvaccinated group were previously infected or not.
Actually, there is some data on this that shows there is a level of immunity among the unvaccinated. We don't know the exact proportion, but we know that it's there - and this is backed up by the ONS antibody data (93.6% of adults with antibodies in w/c 12 July; with around 85% of adults with a first dose only a week prior, I'm being generous.)
Now, the REACT-1 numbers I quoted above include under-18s, who aren't captured in the ONS antibody data. But we know from the separate ONS work that there are antibody levels of around 15% in primary and secondary school kids.
Separately, REACT-2 looks at antibody levels in adults. In their May round, they found prevalence of antibodies in their unvaccinated group was around 13.6%.
It's therefore very difficult to argue that there isn't a level of immunity in the unvaccinated group, though of course we know that the presence of antibodies alone doesn't necessarily prevent infection.
So you're not comparing vaccine performance, based on the level of infection in the vaccinated group, against levels of infection in a totally immunologically naive control group. There's already a level of immunity in the control group, which will reduce the rate of infection in that group. Hence my comment about the impressiveness of the vaccine performance - as it's not being measured against a true control.
It will be interesting to see how the vaccines perform in countries that don't have significant pre-existing infection levels and therefore a small degree of community immunity.